|
US10266585B2
(en)
*
|
2009-08-28 |
2019-04-23 |
The Board Of Regents Of The Univerity Of Texas System |
Methods of treating brain injury
|
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
|
WO2012045882A2
(en)
*
|
2010-10-07 |
2012-04-12 |
Ac Immune S.A. |
Pharmaceutical composition
|
|
LT2627672T
(lt)
|
2010-10-11 |
2018-12-10 |
Biogen International Neuroscience Gmbh |
Žmogaus antikūnai prieš tau baltymą
|
|
WO2012106363A2
(en)
*
|
2011-01-31 |
2012-08-09 |
Intellect Neurosciences Inc. |
Treatment of tauopathies
|
|
GB201112056D0
(en)
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
|
US10307167B2
(en)
|
2012-12-14 |
2019-06-04 |
Corquest Medical, Inc. |
Assembly and method for left atrial appendage occlusion
|
|
US10813630B2
(en)
|
2011-08-09 |
2020-10-27 |
Corquest Medical, Inc. |
Closure system for atrial wall
|
|
US10314594B2
(en)
|
2012-12-14 |
2019-06-11 |
Corquest Medical, Inc. |
Assembly and method for left atrial appendage occlusion
|
|
ES2655051T3
(es)
|
2011-08-26 |
2018-02-16 |
Wisconsin Alumni Research Foundation |
Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas
|
|
JP6358953B2
(ja)
|
2011-10-07 |
2018-07-18 |
エーシー イミューン エス．エー． |
タウを認識するホスホ特異的抗体
|
|
CA2859665C
(en)
|
2011-12-20 |
2024-05-21 |
Janssen Biotech, Inc. |
Anti-phf-tau antibodies and their uses
|
|
CA2869438C
(en)
*
|
2012-04-05 |
2021-08-17 |
Ac Immune S.A. |
Humanized tau antibody
|
|
EP2870176A4
(en)
*
|
2012-07-03 |
2016-09-28 |
Univ Washington |
ANTIBODIES DIRECTED AGAINST TAU
|
|
WO2014016737A1
(en)
*
|
2012-07-24 |
2014-01-30 |
Pfizer Inc. |
Novel chicken monoclonal antibodies against human phosphorylated tau and uses thereof
|
|
EP2885010B1
(en)
*
|
2012-08-16 |
2020-01-01 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
|
US12024568B2
(en)
|
2012-09-13 |
2024-07-02 |
Cornell University |
Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
|
|
US20140142689A1
(en)
|
2012-11-21 |
2014-05-22 |
Didier De Canniere |
Device and method of treating heart valve malfunction
|
|
JP6284548B2
(ja)
|
2012-12-21 |
2018-02-28 |
バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． |
ヒト抗タウ抗体
|
|
US8980270B2
(en)
|
2013-01-18 |
2015-03-17 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
|
MX374811B
(es)
|
2013-03-15 |
2025-03-06 |
Ac Immune Sa |
Anticuerpos anti-tau y métodos de uso.
|
|
EP3003390B1
(en)
|
2013-06-06 |
2021-07-07 |
Pierre Fabre Médicament |
Anti-c10orf54 antibodies and uses thereof
|
|
GB201312226D0
(en)
*
|
2013-07-08 |
2013-08-21 |
Adx Neurosciences |
Improved antibodies
|
|
US9566443B2
(en)
|
2013-11-26 |
2017-02-14 |
Corquest Medical, Inc. |
System for treating heart valve malfunction including mitral regurgitation
|
|
BR112016010454A2
(pt)
*
|
2013-11-27 |
2017-12-05 |
Ipierian Inc |
métodos para tratar uma taupatia
|
|
CR20160270A
(es)
|
2013-12-20 |
2016-09-05 |
Hoffmann La Roche |
ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN
|
|
CN105939722A
(zh)
|
2014-02-14 |
2016-09-14 |
伊皮埃里安股份有限公司 |
Tau肽，抗Tau抗体，及其使用方法
|
|
US10053671B2
(en)
|
2014-06-20 |
2018-08-21 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
AR100978A1
(es)
|
2014-06-26 |
2016-11-16 |
Hoffmann La Roche |
LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS
|
|
TWI734975B
(zh)
|
2014-06-27 |
2021-08-01 |
美商Ｃ２Ｎ醫療診斷有限責任公司 |
人類化抗-tau抗體
|
|
BR112017006419A2
(pt)
|
2014-09-30 |
2017-12-19 |
Univ Washington |
medições cinéticas de tau
|
|
EP3221349B1
(en)
*
|
2014-11-19 |
2020-11-04 |
Axon Neuroscience SE |
Humanized tau antibodies in alzheimer's disease
|
|
US10842626B2
(en)
|
2014-12-09 |
2020-11-24 |
Didier De Canniere |
Intracardiac device to correct mitral regurgitation
|
|
AR103713A1
(es)
|
2015-02-26 |
2017-05-31 |
Lilly Co Eli |
Anticuerpos contra tau y sus usos
|
|
NZ775762A
(en)
|
2015-06-05 |
2025-02-28 |
Genentech Inc |
Anti-tau antibodies and methods of use
|
|
ES2809728T3
(es)
|
2015-06-24 |
2021-03-05 |
Hoffmann La Roche |
Anticuerpos anti-tau(pS422) humanizados y procedimientos de uso
|
|
SG10202010735PA
(en)
|
2015-07-06 |
2020-11-27 |
UCB Biopharma SRL |
Tau-binding antibodies
|
|
JO3711B1
(ar)
*
|
2015-07-13 |
2021-01-31 |
H Lundbeck As |
أجسام مضادة محددة لبروتين تاو وطرق استعمالها
|
|
PT3334761T
(pt)
*
|
2015-08-13 |
2023-08-17 |
Univ New York |
Moléculas baseadas em anticorpo seletivo para o epítopo {p}ser404 da tau e os seus usos no diagnóstico e tratamento de tauopatias
|
|
JP2019510481A
(ja)
|
2016-02-19 |
2019-04-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ワクチン開発のための改善されたｂ型インフルエンザウイルス複製
|
|
JP7029415B2
(ja)
|
2016-07-12 |
2022-03-03 |
ハー・ルンドベック・アクチエゼルスカベット |
過リン酸化タウに特異的な抗体およびその使用方法
|
|
JP6949102B2
(ja)
|
2016-08-09 |
2021-10-13 |
イーライ リリー アンド カンパニー |
併用療法
|
|
EP3551220B1
(en)
*
|
2016-12-07 |
2025-01-29 |
Genentech, Inc. |
Anti-tau antibodies and methods of use
|
|
EP3551655A2
(en)
|
2016-12-07 |
2019-10-16 |
Genentech, Inc. |
Anti-tau antibodies and methods of their use
|
|
US10995137B2
(en)
|
2017-01-04 |
2021-05-04 |
H. Lundbeck A/S |
Antibodies specific for hyperphosphorlated tau for the treatment of ocular diseases
|
|
CA3053379A1
(en)
|
2017-02-17 |
2018-08-23 |
Denali Therapeutics Inc. |
Anti-tau antibodies and methods of use thereof
|
|
JP2018139530A
(ja)
*
|
2017-02-27 |
2018-09-13 |
帝人ファーマ株式会社 |
認知症治療又は予防のためのヒト化抗体及びその製造方法、並びにそれを用いた認知症治療剤又は予防剤
|
|
EA039569B1
(ru)
*
|
2017-03-14 |
2022-02-11 |
Х. Лундбекк А/С |
Антитела, специфичные к гиперфосфорилированному тау-белку, и способы их применения
|
|
TWI771389B
(zh)
|
2017-03-16 |
2022-07-21 |
美商健生生物科技公司 |
抗phf-tau抗體及其用途
|
|
WO2018217630A1
(en)
*
|
2017-05-21 |
2018-11-29 |
University Of Tennessee Research Foundation |
Methods and compositions for targeting tissue lesions
|
|
JP6851549B2
(ja)
|
2017-10-16 |
2021-03-31 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
抗タウ抗体及びその使用
|
|
WO2019084310A1
(en)
|
2017-10-25 |
2019-05-02 |
Yoshihiro Kawaoka |
HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION
|
|
JP7267606B2
(ja)
*
|
2017-11-28 |
2023-05-02 |
国立大学法人三重大学 |
検出方法
|
|
TW201946654A
(zh)
|
2018-03-05 |
2019-12-16 |
比利時商健生藥品公司 |
抗ＰＨＦ－Ｔａｕ抗體及其用途
|
|
EP3829634A1
(en)
|
2018-07-31 |
2021-06-09 |
Eli Lilly and Company |
Combination therapy
|
|
US12343390B2
(en)
|
2018-08-07 |
2025-07-01 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant biologically contained filovirus vaccine
|
|
US11389523B2
(en)
|
2018-08-20 |
2022-07-19 |
Wisconsin Alumni Research Foundation (Warf) |
Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
|
|
US12116415B2
(en)
*
|
2018-10-09 |
2024-10-15 |
Single Cell Technology, Inc. |
Anti-BCMA antibodies
|
|
WO2020077380A1
(en)
*
|
2018-10-17 |
2020-04-23 |
The University Of Queensland |
Methods and compositions for treating tauopathies
|
|
CA3118692A1
(en)
|
2018-11-06 |
2020-05-14 |
Alsatech, Inc. |
Cell-based gene therapy for neurodegenerative diseases
|
|
EP3906055A4
(en)
*
|
2019-01-04 |
2023-01-04 |
Trio Pharmaceuticals, Inc. |
MULTISPECIFIC PROTEIN MOLECULES AND THEIR USES
|
|
WO2020163804A1
(en)
|
2019-02-08 |
2020-08-13 |
Wisconsin Alumni Research Foundation (Warf) |
Humanized cell line
|
|
CN113874078B
(zh)
|
2019-04-05 |
2025-05-06 |
Tauc3生物制品有限公司 |
抗tauc3抗体及其应用
|
|
BR112021017046A2
(pt)
*
|
2019-04-12 |
2021-11-09 |
Phanes Therapeutics Inc |
Receptores de antígeno quiméricos antirreceptores de folato 1 humanizados e seus usos
|
|
CN114929269A
(zh)
|
2019-05-01 |
2022-08-19 |
威斯康星校友研究基金会(Warf) |
用于疫苗开发的改进的流感病毒复制
|
|
CN110028583B
(zh)
*
|
2019-05-07 |
2020-09-11 |
温州医科大学 |
抗Tau抗体及其在治疗阿尔茨海默病、创伤性脑损伤中的应用
|
|
WO2021041624A2
(en)
|
2019-08-27 |
2021-03-04 |
Yoshihiro Kawaoka |
Recombinant influenza viruses with stabilized ha for replication in eggs
|
|
CN112752251B
(zh)
*
|
2019-10-29 |
2022-05-06 |
中国移动通信有限公司研究院 |
一种ue标识符的分配方法、装置和计算机可读存储介质
|
|
JP2023511444A
(ja)
|
2020-01-24 |
2023-03-17 |
ウィスコンシン アルムニ リサーチ ファンデイション |
安定化されたｎａを有する組換えインフルエンザウイルス
|
|
AU2021217290A1
(en)
*
|
2020-02-05 |
2022-07-21 |
Sumitomo Pharma Co., Ltd. |
Determination agent and determination method for tauopathy and dementia-related diseases
|
|
WO2021195410A1
(en)
|
2020-03-25 |
2021-09-30 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant multivalent influenza viruses
|
|
CN116723856A
(zh)
|
2020-06-25 |
2023-09-08 |
默沙东有限责任公司 |
靶向丝氨酸413处磷酸化的tau的高亲和力抗体
|
|
KR20230157296A
(ko)
*
|
2020-12-16 |
2023-11-16 |
보이저 테라퓨틱스, 인크. |
타우 결합 화합물
|
|
EP4014997A1
(en)
|
2020-12-16 |
2022-06-22 |
Consejo Superior de Investigaciones Científicas (CSIC) |
Stard1 inhibitors for the treatment of lysosomal disorders
|
|
US20250276076A1
(en)
*
|
2021-03-18 |
2025-09-04 |
Seagen Inc. |
Anti-alpp/alppl2 antibodies and antibody-drug conjugates
|
|
CL2021001380A1
(es)
|
2021-05-26 |
2022-01-14 |
Corporacion Centro Int De Biomedicina Icc |
Generación de un nuevo anticuerpo monoclonal sitio específico para la proteína tau y su uso como herramienta en biomarcadores específicos para la detección temprana de enfermedades neurodegenerativas y patologías involucradas con la proteína tau como alzheimer y otras demencias.
|
|
WO2023092004A1
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
JP2025535203A
(ja)
|
2022-09-15 |
2025-10-23 |
ボイジャー セラピューティクス インコーポレイテッド |
タウ結合化合物
|
|
EP4658689A2
(en)
*
|
2023-02-02 |
2025-12-10 |
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College |
Phosphomimetic mutants, phosphospecific antibodies, and uses thereof
|
|
WO2025122634A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
WO2025128975A1
(en)
*
|
2023-12-14 |
2025-06-19 |
Immunitas Therapeutics, Inc. |
Cd161 binding proteins and related methods
|
|
WO2025134068A1
(en)
|
2023-12-22 |
2025-06-26 |
Ac Immune Sa |
Antibody drug conjugates targeting proteinopathies, and uses thereof
|
|
WO2026102093A1
(en)
|
2024-11-07 |
2026-05-15 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|